메뉴 건너뛰기




Volumn 3, Issue 9, 2007, Pages 695-703

Hepatitis C virus-related mixed cryoglobulinemia: Pathogenesis, clinical manifestations, and new therapies

Author keywords

B lymphocytes; Cryoglobulinemia; Hepatitis C virus

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; COMPLEMENT COMPONENT C3B; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON; MANNAN BINDING LECTIN; PEGINTERFERON; PEGINTERFERON ALPHA2B; PROTEIN BCL 10; RIBAVIRIN; RITUXIMAB; STEROID; TUMOR NECROSIS FACTOR;

EID: 35348934893     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (20)

References (99)
  • 1
    • 0030955346 scopus 로고    scopus 로고
    • Epidemiology of hepatitis C
    • Alter MJ. Epidemiology of hepatitis C. Hepatology. 1997;26(suppl 1):62S-65S.
    • (1997) Hepatology , vol.26 , Issue.SUPPL. 1
    • Alter, M.J.1
  • 2
    • 0033584440 scopus 로고    scopus 로고
    • The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
    • Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med, 1999;341:556-562.
    • (1999) N Engl J Med , vol.341 , pp. 556-562
    • Alter, M.J.1    Kruszon-Moran, D.2    Nainan, O.V.3
  • 3
    • 20244371123 scopus 로고    scopus 로고
    • Extrahepatic manifestations of hepatitis C among United States male veterans
    • El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002;36:1439-1445.
    • (2002) Hepatology , vol.36 , pp. 1439-1445
    • El-Serag, H.B.1    Hampel, H.2    Yeh, C.3    Rabeneck, L.4
  • 4
    • 0026439201 scopus 로고
    • A role for hepatitis C virus infection in type II cryoglobulinemia
    • Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490-1495.
    • (1992) N Engl J Med , vol.327 , pp. 1490-1495
    • Agnello, V.1    Chung, R.T.2    Kaplan, L.M.3
  • 5
    • 0026674225 scopus 로고
    • Hepatitis C virus infection in patients with essential mixed cryoglobulinemia
    • Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 1992;117:573-577.
    • (1992) Ann Intern Med , vol.117 , pp. 573-577
    • Misiani, R.1    Bellavita, P.2    Fenili, D.3
  • 6
    • 0032475822 scopus 로고    scopus 로고
    • Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-a therapy
    • Neumann AU, Lam NP, Dahati H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-a therapy. Science. 1998;282:103-107.
    • (1998) Science , vol.282 , pp. 103-107
    • Neumann, A.U.1    Lam, N.P.2    Dahati, H.3
  • 12
    • 0028274816 scopus 로고
    • Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage
    • Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology. 1994;106:1291-1300.
    • (1994) Gastroenterology , vol.106 , pp. 1291-1300
    • Lunel, F.1    Musset, L.2    Cacoub, P.3
  • 14
    • 0346666717 scopus 로고    scopus 로고
    • Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients
    • Ni J, Hembrador E, Di Bisceglie AM, et al. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients. J Immunol. 2003;170:3429-3439.
    • (2003) J Immunol , vol.170 , pp. 3429-3439
    • Ni, J.1    Hembrador, E.2    Di Bisceglie, A.M.3
  • 15
    • 0036787033 scopus 로고    scopus 로고
    • Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas
    • Zignego AL, Ferri C, Giannelli F, et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med. 2002;137:571-580.
    • (2002) Ann Intern Med , vol.137 , pp. 571-580
    • Zignego, A.L.1    Ferri, C.2    Giannelli, F.3
  • 16
    • 0033538468 scopus 로고    scopus 로고
    • BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator
    • Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 1999;285:260-263.
    • (1999) Science , vol.285 , pp. 260-263
    • Moore, P.A.1    Belvedere, O.2    Orr, A.3
  • 17
    • 0036732753 scopus 로고    scopus 로고
    • DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
    • Litinskiy MB, Nardelli B, Hubert DM, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002;3:822-829.
    • (2002) Nat Immunol , vol.3 , pp. 822-829
    • Litinskiy, M.B.1    Nardelli, B.2    Hubert, D.M.3
  • 18
    • 16544378081 scopus 로고    scopus 로고
    • The BAFF/APRIL system: An important player in systemic rheumatic diseases
    • Mackay F, Sierro F, Grey ST, Gordon TP. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun. 2005;8:243-265.
    • (2005) Curr Dir Autoimmun , vol.8 , pp. 243-265
    • Mackay, F.1    Sierro, F.2    Grey, S.T.3    Gordon, T.P.4
  • 19
    • 0036498694 scopus 로고    scopus 로고
    • The role of BAFF in B-cell maturation, T-cell activation and autoimmunity
    • Mackay F, Mackay CR. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 2002;23:113-115.
    • (2002) Trends Immunol , vol.23 , pp. 113-115
    • Mackay, F.1    Mackay, C.R.2
  • 20
    • 0035860559 scopus 로고    scopus 로고
    • An essential role for BAFF in the normal development of B ceils through a BCMA-independent pathway
    • Schiemann B, Gommerman JL, Vora K, et al. An essential role for BAFF in the normal development of B ceils through a BCMA-independent pathway. Science. 2001;293:2111-2114.
    • (2001) Science , vol.293 , pp. 2111-2114
    • Schiemann, B.1    Gommerman, J.L.2    Vora, K.3
  • 21
    • 0347285357 scopus 로고    scopus 로고
    • BCMA is essential for the survival of long-lived bone marrow plasma cells
    • O'Connor BP, Raman VS, Erickson LD, et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med. 2004;199:91-98.
    • (2004) J Exp Med , vol.199 , pp. 91-98
    • O'Connor, B.P.1    Raman, V.S.2    Erickson, L.D.3
  • 22
    • 0034596831 scopus 로고    scopus 로고
    • Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response
    • Do RK, Hatada E, Lee H, et al. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med. 2000;192:953-964.
    • (2000) J Exp Med , vol.192 , pp. 953-964
    • Do, R.K.1    Hatada, E.2    Lee, H.3
  • 23
    • 85047690330 scopus 로고    scopus 로고
    • BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
    • Avery DT, Kalled SL, Ellyard JI, et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest. 2003;112:286-297.
    • (2003) J Clin Invest , vol.112 , pp. 286-297
    • Avery, D.T.1    Kalled, S.L.2    Ellyard, J.I.3
  • 24
    • 1842633887 scopus 로고    scopus 로고
    • Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF
    • Lesley R, Xu Y, Kalled SL, et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity. 2004;20:441-453.
    • (2004) Immunity , vol.20 , pp. 441-453
    • Lesley, R.1    Xu, Y.2    Kalled, S.L.3
  • 25
    • 2942518502 scopus 로고    scopus 로고
    • Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches
    • Thien M, Phan TG, Gardam S, et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 2004;20:785-798.
    • (2004) Immunity , vol.20 , pp. 785-798
    • Thien, M.1    Phan, T.G.2    Gardam, S.3
  • 26
    • 0034972257 scopus 로고    scopus 로고
    • Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases
    • Cheema GS, Roschke V, Hubert DM, Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001;44:1313-1319.
    • (2001) Arthritis Rheum , vol.44 , pp. 1313-1319
    • Cheema, G.S.1    Roschke, V.2    Hubert, D.M.3    Stohl, W.4
  • 27
    • 70350612907 scopus 로고    scopus 로고
    • B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome
    • Ittah M, Miceli-Richard C, Eric Gottenberg J, et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome. Arthritis Res Ther. 2006;8:R51.
    • (2006) Arthritis Res Ther , vol.8
    • Ittah, M.1    Miceli-Richard, C.2    Eric Gottenberg, J.3
  • 28
    • 10744224617 scopus 로고    scopus 로고
    • B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observations
    • Stohl W, Metyas S, Tan SM, et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 2003;48:3475-3486.
    • (2003) Arthritis Rheum , vol.48 , pp. 3475-3486
    • Stohl, W.1    Metyas, S.2    Tan, S.M.3
  • 29
    • 0037386743 scopus 로고    scopus 로고
    • Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis
    • Tan SM, Xu D, Roschke V, et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 2003;48:982-992.
    • (2003) Arthritis Rheum , vol.48 , pp. 982-992
    • Tan, S.M.1    Xu, D.2    Roschke, V.3
  • 30
    • 7544245599 scopus 로고    scopus 로고
    • Long-term course of mixed cryoglobulinemia in patients infected with hepatitis C virus
    • Sene D, Ghillani-Dalbin P, Thibault V, et al. Long-term course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J Rheumatol. 2004;31:2199-2206.
    • (2004) J Rheumatol , vol.31 , pp. 2199-2206
    • Sene, D.1    Ghillani-Dalbin, P.2    Thibault, V.3
  • 31
    • 33749514258 scopus 로고    scopus 로고
    • Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity
    • Toubi E, Gordon S, Kessel A, et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun. 2006;27:134-139.
    • (2006) J Autoimmun , vol.27 , pp. 134-139
    • Toubi, E.1    Gordon, S.2    Kessel, A.3
  • 32
    • 33845575045 scopus 로고    scopus 로고
    • B-lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection
    • Fabtis M, Quartuccio L, Sacco S, et al. B-lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection. Rheumatology (Oxford). 2007;46:37-43.
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 37-43
    • Fabtis, M.1    Quartuccio, L.2    Sacco, S.3
  • 33
    • 4544298413 scopus 로고    scopus 로고
    • Differences in the relationship of specificity to titre and functional affinity between circulating Ga- and pan-reactive IgM rheumatoid factors in rheumatoid arthritis
    • Milosević-Jovcić N, Ciric D, Hajduković- Dragojlović L, Mircetić V. Differences in the relationship of specificity to titre and functional affinity between circulating Ga- and pan-reactive IgM rheumatoid factors in rheumatoid arthritis. Rheumatology (Oxford). 2004;43:1190-1193.
    • (2004) Rheumatology (Oxford) , vol.43 , pp. 1190-1193
    • Milosević-Jovcić, N.1    Ciric, D.2    Hajduković- Dragojlović, L.3    Mircetić, V.4
  • 34
    • 33744495071 scopus 로고    scopus 로고
    • HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations
    • De Re V, Sansonno D, Simula MP, et al. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia. 2006;20:1145-1154.
    • (2006) Leukemia , vol.20 , pp. 1145-1154
    • De Re, V.1    Sansonno, D.2    Simula, M.P.3
  • 35
    • 0030965840 scopus 로고    scopus 로고
    • Role of repetitive antigen patterns for induction of antibodies against antibodies
    • Feht T, Bachmann MF, Bucher E, et al. Role of repetitive antigen patterns for induction of antibodies against antibodies. J Exp Med. 1997;185:1785-1792.
    • (1997) J Exp Med , vol.185 , pp. 1785-1792
    • Feht, T.1    Bachmann, M.F.2    Bucher, E.3
  • 36
    • 0033867014 scopus 로고    scopus 로고
    • The lymphoid system in hepatitis C virus infection: Autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy
    • Dammacco F, Sansonno D, Piccoli C, et al. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. Semin Liver Dis. 2000;20:143-157.
    • (2000) Semin Liver Dis , vol.20 , pp. 143-157
    • Dammacco, F.1    Sansonno, D.2    Piccoli, C.3
  • 37
    • 0038185193 scopus 로고    scopus 로고
    • Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver
    • Curry MP, Golden-Mason L, Doherty DG, et al. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol. 2003;38:642-650.
    • (2003) J Hepatol , vol.38 , pp. 642-650
    • Curry, M.P.1    Golden-Mason, L.2    Doherty, D.G.3
  • 38
    • 0030829376 scopus 로고    scopus 로고
    • High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy
    • De Rosa G, Gobbo ML, De Renzo A, et al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol. 1997;55:77-82.
    • (1997) Am J Hematol , vol.55 , pp. 77-82
    • De Rosa, G.1    Gobbo, M.L.2    De Renzo, A.3
  • 40
    • 17644448915 scopus 로고    scopus 로고
    • Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas
    • Silvestri F, Barillari G, Fanin R, et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica. 1997;82:314-317.
    • (1997) Haematologica , vol.82 , pp. 314-317
    • Silvestri, F.1    Barillari, G.2    Fanin, R.3
  • 41
    • 9444296054 scopus 로고    scopus 로고
    • Hepatitis C virus and non-Hodgkin's lymphomas
    • Mazzaro C, Zagonel V, Monfardini S, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol. 1996;94:544-550.
    • (1996) Br J Haematol , vol.94 , pp. 544-550
    • Mazzaro, C.1    Zagonel, V.2    Monfardini, S.3
  • 42
    • 3042767356 scopus 로고    scopus 로고
    • Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients
    • Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33:355-374.
    • (2004) Semin Arthritis Rheum , vol.33 , pp. 355-374
    • Ferri, C.1    Sebastiani, M.2    Giuggioli, D.3
  • 43
    • 0037063113 scopus 로고    scopus 로고
    • Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection
    • Hermine O, Lefrère F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89-94.
    • (2002) N Engl J Med , vol.347 , pp. 89-94
    • Hermine, O.1    Lefrère, F.2    Bronowicki, J.P.3
  • 44
    • 0033428703 scopus 로고    scopus 로고
    • Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations
    • Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med. 1999;190:1697-1710.
    • (1999) J Exp Med , vol.190 , pp. 1697-1710
    • Mackay, F.1    Woodcock, S.A.2    Lawton, P.3
  • 45
    • 13844306871 scopus 로고    scopus 로고
    • Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: Electrophysiologic follow-up study
    • Ammendola A, Sampaolo S, Ambrosone L, et al. Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study. Muscle Nerve. 2005;31:382-385.
    • (2005) Muscle Nerve , vol.31 , pp. 382-385
    • Ammendola, A.1    Sampaolo, S.2    Ambrosone, L.3
  • 46
    • 33747841969 scopus 로고    scopus 로고
    • Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection
    • Boukhris S, Magy L, Senga-mokono U, et al. Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection. Eur J Neurol. 2006;13:937-941.
    • (2006) Eur J Neurol , vol.13 , pp. 937-941
    • Boukhris, S.1    Magy, L.2    Senga-mokono, U.3
  • 47
    • 18744399909 scopus 로고    scopus 로고
    • Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: A model of infection-driven lymphomagenesis
    • Carbonari M, Caprini E, Tedesco T, et al. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis. J Immunol. 2005;174:6532-6539.
    • (2005) J Immunol , vol.174 , pp. 6532-6539
    • Carbonari, M.1    Caprini, E.2    Tedesco, T.3
  • 48
    • 0028130633 scopus 로고
    • Renal manifestations of hepatitis C virus infection
    • Johnson RJ, Willson R, Yamabe H, et al. Renal manifestations of hepatitis C virus infection. Kidney Int. 1994;46:1255-1263.
    • (1994) Kidney Int , vol.46 , pp. 1255-1263
    • Johnson, R.J.1    Willson, R.2    Yamabe, H.3
  • 49
    • 0031823457 scopus 로고    scopus 로고
    • Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis
    • D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int. 1998;54:650-671.
    • (1998) Kidney Int , vol.54 , pp. 650-671
    • D'Amico, G.1
  • 50
    • 33845592773 scopus 로고    scopus 로고
    • Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis
    • Roccatello D, Fornasieri A, Giachino O, et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis. 2007;49:69-82.
    • (2007) Am J Kidney Dis , vol.49 , pp. 69-82
    • Roccatello, D.1    Fornasieri, A.2    Giachino, O.3
  • 51
    • 85002153461 scopus 로고    scopus 로고
    • Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis
    • Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology. 2002;36(4 pt 1):978-985.
    • (2002) Hepatology , vol.36 , Issue.4 PART 1 , pp. 978-985
    • Kayali, Z.1    Buckwold, V.E.2    Zimmerman, B.3    Schmidt, W.N.4
  • 52
    • 4444312093 scopus 로고    scopus 로고
    • Cryoglobulinemia and progression of fibrosis in chronic HCV infection: Cause or effect?
    • Siagris D, Christofidou M, Tsamandas A, et al. Cryoglobulinemia and progression of fibrosis in chronic HCV infection: cause or effect? J Infect. 2004;49:236-241.
    • (2004) J Infect , vol.49 , pp. 236-241
    • Siagris, D.1    Christofidou, M.2    Tsamandas, A.3
  • 53
    • 33745572348 scopus 로고    scopus 로고
    • Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C
    • Saadoun D, Asselah T, Resche-Rigon M, et al. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology. 2006;43:1337-1345.
    • (2006) Hepatology , vol.43 , pp. 1337-1345
    • Saadoun, D.1    Asselah, T.2    Resche-Rigon, M.3
  • 54
    • 33646730482 scopus 로고    scopus 로고
    • Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach
    • Lee IN, Chen CH, Sheu JC, et al. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. Proteomics. 2006;6:2865-2873.
    • (2006) Proteomics , vol.6 , pp. 2865-2873
    • Lee, I.N.1    Chen, C.H.2    Sheu, J.C.3
  • 55
    • 0028090092 scopus 로고
    • Hypocomplementemia associated with hepatitis C viremia in sera from voluntary blood donors
    • Itoh K, Tanaka H, Shiga J, et al. Hypocomplementemia associated with hepatitis C viremia in sera from voluntary blood donors. Am J Gastroenterol. 1994;89:2019-2024.
    • (1994) Am J Gastroenterol , vol.89 , pp. 2019-2024
    • Itoh, K.1    Tanaka, H.2    Shiga, J.3
  • 56
    • 0343183463 scopus 로고
    • A new complement function: Solubilization of antigen-antibody aggregates
    • Miller GW, Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Set U S A. 1975;72:418-422.
    • (1975) Proc Natl Acad Set U S A , vol.72 , pp. 418-422
    • Miller, G.W.1    Nussenzweig, V.2
  • 57
    • 0021796688 scopus 로고
    • Interaction of complement solubilized complexes with mouse peritoneal macrophages and their clearance and tissue uptake
    • Takahashi N, Fujita T, Takata Y, Tamura N. Interaction of complement solubilized complexes with mouse peritoneal macrophages and their clearance and tissue uptake. Clin Exp Immunol. 1985;61:176-182.
    • (1985) Clin Exp Immunol , vol.61 , pp. 176-182
    • Takahashi, N.1    Fujita, T.2    Takata, Y.3    Tamura, N.4
  • 58
    • 0022352363 scopus 로고
    • Complement-mediated solubilization of immune complexes and their interaction with complement C3 receptors
    • Petersen I, Baatrup G, Jepsen HH, Svehag SE. Complement-mediated solubilization of immune complexes and their interaction with complement C3 receptors. Complement. 1985;2:97-110.
    • (1985) Complement , vol.2 , pp. 97-110
    • Petersen, I.1    Baatrup, G.2    Jepsen, H.H.3    Svehag, S.E.4
  • 59
    • 0028512757 scopus 로고
    • Complement mediated solubilization: Role of the complement in the clearance of circulating immune-complexes
    • Sanchez-Cuenca JM. Complement mediated solubilization: role of the complement in the clearance of circulating immune-complexes. Allergol Immunopathol (Madr). 1994;22:197-203.
    • (1994) Allergol Immunopathol (Madr) , vol.22 , pp. 197-203
    • Sanchez-Cuenca, J.M.1
  • 60
    • 0020628210 scopus 로고
    • Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system
    • Skogh T, Stendahl O. Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system. Immunology. 1983;49:53-59.
    • (1983) Immunology , vol.49 , pp. 53-59
    • Skogh, T.1    Stendahl, O.2
  • 61
    • 0027365485 scopus 로고
    • Decreased activity of complement-mediated immune complex clearance in hemodialysis patients
    • Inagi R, Miyata T, Hong K, et al. Decreased activity of complement-mediated immune complex clearance in hemodialysis patients. Clin Immunol Immunopathol. 1993;68:333-339.
    • (1993) Clin Immunol Immunopathol , vol.68 , pp. 333-339
    • Inagi, R.1    Miyata, T.2    Hong, K.3
  • 62
    • 33644847301 scopus 로고    scopus 로고
    • The mannan-binding lectin (MBL) pathway of complement activation: Biochemistry, biology and clinical implications
    • Jensenius JC. The mannan-binding lectin (MBL) pathway of complement activation: biochemistry, biology and clinical implications. Adv Exp Med Biol. 2005;564:21-22.
    • (2005) Adv Exp Med Biol , vol.564 , pp. 21-22
    • Jensenius, J.C.1
  • 63
    • 33845473916 scopus 로고    scopus 로고
    • Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-I) complex
    • Brown KS, Keogh MJ, Tagiuri N, et al. Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-I) complex. Clin Exp Immunol. 2007;147:90-98.
    • (2007) Clin Exp Immunol , vol.147 , pp. 90-98
    • Brown, K.S.1    Keogh, M.J.2    Tagiuri, N.3
  • 64
    • 33845615869 scopus 로고    scopus 로고
    • Mannan binding lectin and viral hepatitis
    • Brown KS, Ryder SD, Irving WL, et al. Mannan binding lectin and viral hepatitis. Immunol Lett. 2007;108:34-44.
    • (2007) Immunol Lett , vol.108 , pp. 34-44
    • Brown, K.S.1    Ryder, S.D.2    Irving, W.L.3
  • 65
    • 35348968297 scopus 로고    scopus 로고
    • Clinical spectrum of chronic hepatitis C virus-related cryoglobulinemia in the US
    • Presented at, May 19-24, Washington, DC. Abstract M1838
    • Al Sibae M, Jacobson IM, Lake-Bakaar G. Clinical spectrum of chronic hepatitis C virus-related cryoglobulinemia in the US. Presented at Digestive Disease Week, May 19-24, 2007, Washington, DC. Abstract M1838.
    • (2007) Digestive Disease Week
    • Al Sibae, M.1    Jacobson, I.M.2    Lake-Bakaar, G.3
  • 66
    • 0034782263 scopus 로고    scopus 로고
    • Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment
    • Schott P, Hartmann H, Ramadori G. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment. Histol Histopathol. 2001;16:1275-1285.
    • (2001) Histol Histopathol , vol.16 , pp. 1275-1285
    • Schott, P.1    Hartmann, H.2    Ramadori, G.3
  • 67
    • 0029551887 scopus 로고
    • Guidelines for the management of essential mixed cryoglobulinemia
    • Tavoni A, Mosca M, Ferri C, et al. Guidelines for the management of essential mixed cryoglobulinemia. Clin Exp Rheumatol. 1995;13(suppl 13):S191-SI95.
    • (1995) Clin Exp Rheumatol , vol.13 , Issue.SUPPL. 13
    • Tavoni, A.1    Mosca, M.2    Ferri, C.3
  • 68
    • 0001451871 scopus 로고    scopus 로고
    • Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemta
    • Gordon AC, Edgar JD, Finch RG. Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemta. J Infect. 1998;36:229-230.
    • (1998) J Infect , vol.36 , pp. 229-230
    • Gordon, A.C.1    Edgar, J.D.2    Finch, R.G.3
  • 69
    • 0036266581 scopus 로고    scopus 로고
    • Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: A case report and literature review
    • Boonyapisit K, Katirji B. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve. 2002;25:909-913.
    • (2002) Muscle Nerve , vol.25 , pp. 909-913
    • Boonyapisit, K.1    Katirji, B.2
  • 70
    • 0032972998 scopus 로고    scopus 로고
    • Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin
    • Misiani R, Bellavita P, Baio P, et al. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin. Nephrol Dial Transplant. 1999;14:1558-1560.
    • (1999) Nephrol Dial Transplant , vol.14 , pp. 1558-1560
    • Misiani, R.1    Bellavita, P.2    Baio, P.3
  • 71
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW, Shiftman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975-982.
    • (2002) N Engl J Med , vol.347 , pp. 975-982
    • Fried, M.W.1    Shiftman, M.L.2    Reddy, K.R.3
  • 72
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
    • Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958-965.
    • (2001) Lancet , vol.358 , pp. 958-965
    • Manns, M.P.1    McHutchison, J.G.2    Gordon, S.C.3
  • 73
    • 33845449051 scopus 로고    scopus 로고
    • Peginterferon and ribavirin for chronic hepatitis C
    • Hoofnagle JH, Seeff LB. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 2006;355:2444-2451.
    • (2006) N Engl J Med , vol.355 , pp. 2444-2451
    • Hoofnagle, J.H.1    Seeff, L.B.2
  • 74
    • 14944373284 scopus 로고    scopus 로고
    • PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis
    • Cacoub P, Saadoun D, Limal N, et al. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2005;52:911-915.
    • (2005) Arthritis Rheum , vol.52 , pp. 911-915
    • Cacoub, P.1    Saadoun, D.2    Limal, N.3
  • 75
    • 0038603204 scopus 로고    scopus 로고
    • Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20
    • Sansonno D, De Re V, Lauletta G, et al. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood. 2003;101:3818-3826.
    • (2003) Blood , vol.101 , pp. 3818-3826
    • Sansonno, D.1    De Re, V.2    Lauletta, G.3
  • 76
    • 33847366355 scopus 로고    scopus 로고
    • Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario
    • Cheung MC, Haynes AE, Meyer RM, et al. Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario. Cancer Treat Rev. 2007;33:161-176.
    • (2007) Cancer Treat Rev , vol.33 , pp. 161-176
    • Cheung, M.C.1    Haynes, A.E.2    Meyer, R.M.3
  • 77
    • 0028057250 scopus 로고
    • Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
    • Reff ME, Carner K, Chambers KS, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994;83:435-445.
    • (1994) Blood , vol.83 , pp. 435-445
    • Reff, M.E.1    Carner, K.2    Chambers, K.S.3
  • 78
    • 33747184593 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with rituximab: An update and possible indications
    • De Vita S, Quartuccio L. Treatment of rheumatoid arthritis with rituximab: an update and possible indications. Autoimmun Rev. 2006;5:443-448.
    • (2006) Autoimmun Rev , vol.5 , pp. 443-448
    • De Vita, S.1    Quartuccio, L.2
  • 79
    • 0036177103 scopus 로고    scopus 로고
    • Rituximab: Ongoing and future clinical development
    • Grillo-Lopez AJ, Hedrick E, Rashford M, Benyunes M. Rituximab: ongoing and future clinical development. Semin Oncol. 2002;29(1 suppl 2):105-112.
    • (2002) Semin Oncol , vol.29 , Issue.1 SUPPL. 2 , pp. 105-112
    • Grillo-Lopez, A.J.1    Hedrick, E.2    Rashford, M.3    Benyunes, M.4
  • 80
    • 0036674876 scopus 로고    scopus 로고
    • B cell-ablative therapy for the treatment of autoimmune diseases
    • Patel DD. B cell-ablative therapy for the treatment of autoimmune diseases. Arthritis Rheum. 2002;46:1984-1985.
    • (2002) Arthritis Rheum , vol.46 , pp. 1984-1985
    • Patel, D.D.1
  • 81
    • 10744226311 scopus 로고    scopus 로고
    • Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis
    • Lamprecht P, Lerin-Lozano C, Merz H, et al. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis. 2003;62:1230-1233.
    • (2003) Ann Rheum Dis , vol.62 , pp. 1230-1233
    • Lamprecht, P.1    Lerin-Lozano, C.2    Merz, H.3
  • 82
    • 0037926826 scopus 로고    scopus 로고
    • Efficacy and safety of rituximab in type II mixed cryoglobulinemia
    • Zaja F, De Vita S, Mazzaro C, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood. 2003;101:3827-3834.
    • (2003) Blood , vol.101 , pp. 3827-3834
    • Zaja, F.1    De Vita, S.2    Mazzaro, C.3
  • 83
    • 19944429904 scopus 로고    scopus 로고
    • Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis
    • Roccatello D, Baldovino S, Rossi D, et al. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant. 2004;19:3054-3061.
    • (2004) Nephrol Dial Transplant , vol.19 , pp. 3054-3061
    • Roccatello, D.1    Baldovino, S.2    Rossi, D.3
  • 84
    • 29344438003 scopus 로고    scopus 로고
    • Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients
    • Basse G, Ribes D, Kamar N, et al. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients. Transplantation. 2005;80:1560-1564.
    • (2005) Transplantation , vol.80 , pp. 1560-1564
    • Basse, G.1    Ribes, D.2    Kamar, N.3
  • 85
    • 33745631505 scopus 로고    scopus 로고
    • Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: Efficacy and safety in the absence of steroids
    • Quartuccio L, Soardo G, Romano G, et al. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford). 2006;45:842-846.
    • (2006) Rheumatology (Oxford) , vol.45 , pp. 842-846
    • Quartuccio, L.1    Soardo, G.2    Romano, G.3
  • 86
    • 33846243704 scopus 로고    scopus 로고
    • Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: Evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease
    • Lake-Bakaar G, Dustin L, McKeating J, et al. Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease. Blood. 2007;109:845-846.
    • (2007) Blood , vol.109 , pp. 845-846
    • Lake-Bakaar, G.1    Dustin, L.2    McKeating, J.3
  • 87
    • 33646736312 scopus 로고    scopus 로고
    • Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient
    • Aksoy S, Abali H, Kilickap S, et al. Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient. Clin Lab Haematol. 2006;28:211-214.
    • (2006) Clin Lab Haematol , vol.28 , pp. 211-214
    • Aksoy, S.1    Abali, H.2    Kilickap, S.3
  • 88
    • 8444243285 scopus 로고    scopus 로고
    • Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP
    • Dai MS, Chao TY, Kao WY, et al. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP. Ann Hematol. 2004;83:769-774.
    • (2004) Ann Hematol , vol.83 , pp. 769-774
    • Dai, M.S.1    Chao, T.Y.2    Kao, W.Y.3
  • 89
    • 0347899282 scopus 로고    scopus 로고
    • Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma
    • Tsutsumi Y, Tanaka J, Kawamura T, et al. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma. Ann Hematol. 2004;83:58-60.
    • (2004) Ann Hematol , vol.83 , pp. 58-60
    • Tsutsumi, Y.1    Tanaka, J.2    Kawamura, T.3
  • 90
    • 0034799485 scopus 로고    scopus 로고
    • Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: Case report
    • Ng HJ, Lim LC. Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report. Ann Hematol. 2001;80:549-552.
    • (2001) Ann Hematol , vol.80 , pp. 549-552
    • HJ, N.1    Lim, L.C.2
  • 91
    • 12544255423 scopus 로고    scopus 로고
    • Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab
    • Zell JA, Yoon EJ, Ignatius Ou SH, et al. Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab. Anticancer Drugs. 2005;16:83-85.
    • (2005) Anticancer Drugs , vol.16 , pp. 83-85
    • Zell, J.A.1    Yoon, E.J.2    Ignatius, O.S.3
  • 92
    • 10244228057 scopus 로고    scopus 로고
    • Hepatitis B reactivation in a patient receiving radiolabeled rituximab
    • Soong YL, Lee KM, Lui HF, et al. Hepatitis B reactivation in a patient receiving radiolabeled rituximab. Ann Hematol. 2005;84:61-62.
    • (2005) Ann Hematol , vol.84 , pp. 61-62
    • Soong, Y.L.1    Lee, K.M.2    Lui, H.F.3
  • 93
    • 10744227909 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: Necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy
    • Tsutsumi Y, Kawamura T, Saitoh S, et al. Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy. Leuk Lymphoma. 2004;45:627-629.
    • (2004) Leuk Lymphoma , vol.45 , pp. 627-629
    • Tsutsumi, Y.1    Kawamura, T.2    Saitoh, S.3
  • 94
    • 8444220528 scopus 로고    scopus 로고
    • Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab
    • Hernandez JA, Diloy R, Salat D, et al. Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab. Haematologica. 2003;88:ECR22.
    • (2003) Haematologica , vol.88
    • Hernandez, J.A.1    Diloy, R.2    Salat, D.3
  • 95
    • 22144436318 scopus 로고    scopus 로고
    • Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations
    • Law JK, Ho JK, Hoskins PJ, et al. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk Lymphoma. 2005;46:1085-1089.
    • (2005) Leuk Lymphoma , vol.46 , pp. 1085-1089
    • Law, J.K.1    Ho, J.K.2    Hoskins, P.J.3
  • 96
    • 24044431565 scopus 로고    scopus 로고
    • HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb
    • Sarrecchia C, Cappelli A, Aiello P. HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. J Infect Chemother. 2005;11:189-191.
    • (2005) J Infect Chemother , vol.11 , pp. 189-191
    • Sarrecchia, C.1    Cappelli, A.2    Aiello, P.3
  • 97
    • 0042941863 scopus 로고    scopus 로고
    • Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy
    • Westhoff TH, Jochimsen F, Schmittel A, et al. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood. 2003;102:1930.
    • (2003) Blood , vol.102 , pp. 1930
    • Westhoff, T.H.1    Jochimsen, F.2    Schmittel, A.3
  • 98
    • 33644545429 scopus 로고    scopus 로고
    • Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy
    • Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology. 2006;43:209-220.
    • (2006) Hepatology , vol.43 , pp. 209-220
    • Yeo, W.1    Johnson, P.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.